Refine by
Anemia Articles & Analysis
27 news found
It is has been effective in preclinical studies in a broad range of conditions including, hemorrhagic shock, traumatic brain injury, stroke, sickle cell anemia and a host of other conditions. The primary mechanism of action of VitalHeme is dismutation of vascular superoxide, in which it outperforms native superoxide dismutase. ...
They are hard to diagnose using traditional methods as they present as a number of nonspecific symptoms, such as severe hypertension, acute kidney injury/failure in the context of mechanical anemia and thrombocytopenia. TMAs lesions can be associated with many diseases and some genetic disorders linked to aHUS. ...
The most frequent treatment-emergent adverse events (AEs) determined to be possibly related to tulmimetostat included thrombocytopenia (47.1%), diarrhea (37.3%), nausea (29.4%), anemia (27.5%), fatigue (25.5%), neutropenia (17.6%), dysgeusia (17.6%), alopecia (15.7%) and vomiting (15.7%). ...
” Lenalidomide The lenalidomide API provided by Alfa Chemistry can be used in research applications or medication production for the treatment of cancerous and anemia patients who are suffering from certain blood/bone marrow disorders. ...
The most common hematologic treatment-emergent adverse event (AE) of any grade was thrombocytopenia, which was reported in 55% (grade ≥3: 18%) of patients. Anemia was reported in 43% (grade ≥3: 34%) of patients. The most common (≥25%) nonhematologic treatment-emergent AEs of any grade were diarrhea (43%), respiratory tract infection (41%), asthenic conditions (38%), ...
BillionToOne , Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of their UNITY fetal antigen single-gene non-invasive prenatal test (sgNIPT), a new addition to UNITY Screen. For pregnant patients who are alloimmunized with C, c, D, E, Duffy (Fya), or Kell (K) red blood cell (RBC) antibodies, this novel NIPT ...
Grafalon ® (Anti-Human T Cell Rabbit Immunoglobulin, ATLG, also known as "ATG-FreseniusS" and "ATG-F"), developed by Neovii and approved in more than 50 countries to improve outcomes for transplant recipients , and in some countries for the treatment of aplastic anemia. Grafalon® has a solid clinical experience benefiting more than 250,000 patients and is a leader in many ...
Rocket's clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult-to-treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections that are frequently fatal, and ...
About FeraMAX® FeraMAX® Pd Therapeutic 150 is an oral iron supplement indicated for the treatment of iron deficiency anemia. It is a patented formulation and the only Polydextrose-lron Complex (PDIC) in Canada. ...
The most frequently reported AEs in the treatment arms (darolutamide plus ADT and docetaxel versus ADT plus docetaxel) were alopecia (40.5% and 40.6%, respectively), neutropenia (39.3% and 38.8, respectively), fatigue (33.1% and 32.9%, respectively) and anemia (27.8% and 25.1%, respectively). Grade 3 or 4 AEs reported in 66.1% versus 63.5% of patients were mainly due to ...
ByBayer AG
One serious adverse event of sickle cell anemia with crisis (vaso-occlusive crisis or VOC) was reported approximately nine months after treatment with SAR445136 in one patient, and no other SCD-related events were reported in the four patients post-infusion. ...
One serious adverse event of sickle cell anemia with crisis (vaso-occlusive crisis or VOC) was reported approximately nine months after treatment with SAR445136 in one patient, and no other SCD-related events were reported in the four patients post-infusion. ...
” The second study presented titled “True Anemia in Heart Failure Patients: Peripheral Hematocrits Lack Sensitivity and Specificity as a Predictor of Measured Red Blood Cell Volumes in a Mixed-LVEF Cohort,” examined three hematocrit (Hct) thresholds in a cohort of 245 heart failure patients for determining true anemia as measured by BVA. The ...
Iron sucrose injection is commonly prescribed for iron-deficiency anemia treatment. Ferric iron (iron(III)) and sucrose are the main components of the injection. ...
Topline results from the ADP-A2AFP Phase 1 trial as of the April 5, 2021 data cutoff Efficacy Thirteen patients with advanced hepatocellular carcinoma (HCC) received ADP-A2AFP in Cohort 3 and expansion The best overall responses in Cohort 3 and expansion (per RECIST v1.1) included 1 complete response (reported in 2020), 6 stable disease and 4 progressive disease. 2 patients did not have scan ...
MCHC, along with measured hemoglobin and hematocrit, provides insight into the severity and cause of certain anemias. No other critical care blood gas analyzer has this unique capability. Low MCHC, associated with hypochromic anemias, can indicate internal bleeding, anemia of chronic disease, chronic low grade blood loss, iron deficiency, and ...
The most common AEs included nasopharyngitis, anemia and headache for both placebo and mirikizumab-treated patients. ...
In my lifetime alone, the biotech industry has been able to triple the life expectancy of patients with cystic fibrosis, come close to ending the scourge of sickle cell anemia, and turn HIV into a chronic disease by listening to new information. ...
The most frequent adverse reactions (>2%) associated with dose interruption were neutropenia, anemia, thrombocytopenia, leukopenia, upper respiratory tract infection, fatigue, nausea, and ILD. ...
About Grafalon® Grafalon® (formerly commercialized as ATG Fresenius), is a rabbit anti-human T-lymphocyte immunoglobulin, used as part of immunosuppressive regimens for the prevention of graft versus host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation or as immunosuppressive in the treatment of aplastic anemia ...